| Followers | 35 |
| Posts | 1914 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Sunday, August 17, 2025 8:44:39 PM
Well, it looks like it's time for me to show up on your board and smash this thing into pieces.
I see a lot of folks here who have no idea about science nor science literature. This is going to be a good one!
Let's just start right at the very basics - no scientific knowledge required.
Scam red flag number 1 and 2: When the headquarter address is a virtual office and the phone number used is not a direct line (it's even on a robocall list!).
For a "promising biotech" that does seem strange, wouldn't you say? 🤣🤣
Where is the peer-reviewed paper?
All I see are papers written and funded by Vivos. How convenient. It always appears on the OTC that biotech's love to "produce products" that never have peer-reviewed papers. I mean, after all, if this was so innovative, unique and prosperous why wouldn't any big pharma want to buy its patents or fund it? Big pharma is always searching for that next revenue generating idea.
Yet, more funding through debt and dilution? Interesting....
After looking over the patents and "research papers" it appears there is nothing special about this medical device. In fact, it's already been done before by quite a few different research institutions and biotech's/pharmaceutical companies.
Has no one ever heard of nanogels? OncoGel? Different type of radioisotopes? Cancer vaccines? Theranostics?
What this company is is nothing more than a great ruse. A mash up of different scientific research papers. I see nothing special here with their "medical device" that has not already been done decades ago.
I see a lot of folks here who have no idea about science nor science literature. This is going to be a good one!
Let's just start right at the very basics - no scientific knowledge required.
Scam red flag number 1 and 2: When the headquarter address is a virtual office and the phone number used is not a direct line (it's even on a robocall list!).
For a "promising biotech" that does seem strange, wouldn't you say? 🤣🤣
Where is the peer-reviewed paper?
All I see are papers written and funded by Vivos. How convenient. It always appears on the OTC that biotech's love to "produce products" that never have peer-reviewed papers. I mean, after all, if this was so innovative, unique and prosperous why wouldn't any big pharma want to buy its patents or fund it? Big pharma is always searching for that next revenue generating idea.
Yet, more funding through debt and dilution? Interesting....
After looking over the patents and "research papers" it appears there is nothing special about this medical device. In fact, it's already been done before by quite a few different research institutions and biotech's/pharmaceutical companies.
Has no one ever heard of nanogels? OncoGel? Different type of radioisotopes? Cancer vaccines? Theranostics?
What this company is is nothing more than a great ruse. A mash up of different scientific research papers. I see nothing special here with their "medical device" that has not already been done decades ago.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
